| Literature DB >> 19710292 |
George F Santos1, Marzia Giuliani, Laura Santini, Jeanette Adu-Bobie, Mariagrazia Pizza, Rino Rappuoli, William Wacknov, John Donnelly.
Abstract
The induction of resistance by immune selective pressure to bactericidal antibodies from humans immunized with Novartis recombinant meningococcal group B vaccines was assessed. Serum bactericidal antibody titers against selected bacteria were within assay variability through a selection event frequency of 1 in 10(-5). No change in antigen expression was observed by Western blotting.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19710292 PMCID: PMC2772378 DOI: 10.1128/CVI.00125-09
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X